A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

Qaiser Bashir, Hassan Khan, Peter F. Thall, Ping Liu, Nina Shah, Partow Kebriaei, Simrit Parmar, Betul Oran, Stefan Ciurea, Yago Nieto, Roy Jones, Chitra M. Hosing, Uday R. Popat, Yvonne T. Dinh, Gabriela Rondon, Robert Z. Orlowski, Jatin J. Shah, Marcos De Lima, Elizabeth Shpall, Richard ChamplinSergio Giralt, Muzaffar H. Qazilbash

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences